🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of X-82 in...
Status
Terminated
Location
Multiple Locations
Start Date
2015-03-16
Trial ID
NCT02348359
The French CODEX study is designed as a national database to describe, in r...
Status
Completed
Location
Multiple Locations
Start Date
2016-09-30
Trial ID
NCT02811692
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested
The centre of the retina (macula) at the back of the eye contains cells tha...
Status
Recruiting
Location
University of Bonn
Start Date
2021-04-16
Trial ID
NCT04663750
Treatments Being Tested
To assess the efficacy of intravitreal (IVT) administration of aflibercept ...
Status
Completed
Location
Multiple Locations
Start Date
2014-12-19
Trial ID
NCT02305238
Treatments Being Tested
This will be a randomized, comparative, parallel, clinical study to assess ...
Status
Recruiting
Location
CBCC Global Research Site:005
Start Date
2023-12-22
Trial ID
NCT06132035
Treatments Being Tested
The purpose of this prospective interventional study is to assess whether a...
Status
Withdrawn
Location
Duke Eye Center
Start Date
2016-01
Trial ID
NCT02457026
Treatments Being Tested
The purpose of this Phase II study will be to investigate the antiangiogeni...
Status
Completed
Location
Florida Cancer Specialists
Start Date
2013-01
Trial ID
NCT01749956
Treatments Being Tested
The study is designed for multi-center,randomized,double-masked,active-cont...
Status
Active Not Recruiting
Location
Shanghai General Hospital
Start Date
2023-09-21
Trial ID
NCT05972473
Treatments Being Tested
This phase I trial studies the side effects and best dose of ziv-aflibercep...
Status
Active Not Recruiting
Location
Moffitt Cancer Center-International Plaza
Start Date
2015-04-08
Trial ID
NCT02298959